I can speak from a FINTRAC perspective. We've always had a relationship with our partners internationally. FinCEN, for example, in the U.S., is a partner that we share intelligence back and forth with. We share typology. We exchange on trends and what they see on the ground, etc., and we do the same. There's an active partnership there that has never really ceased. It has continued despite everything that's been going on.
I would also say that FINTRAC is positioning itself to be agile. When things are popping up, we can move our teams and so forth. One of the examples is all the efforts that we've made in terms of the fight against the illegal fentanyl. Since last year, we've redeployed existing resources. We've brought them directly to our disclosure recipient, so they could be there, hear, and then come back. This way, we keep at arm's length but work on what our disclosure recipient needs as far as information in order to combat illicit drugs.